Search for: Twitter YouTube LinkedIn Email Request Info Notice to Recruiters and Search Firms Personalis makes every effort to source and hire its staff through direct recruitment methods. Employment opportunities at Personalis are managed by our internal Human Resources team. Please do not contact other Personalis employees. Personalis does not accept unsolicited resumes from any source other than from the candidates themselves. Personalis does not accept unsolicited communications from external recruiters. If there is a specific business need, a Human Resources team member will contact external recruiters directly. An agency or independent recruiter must have a current, signed agreement and a work order for a specific position with Personalis before presenting candidates and must be presented to Human Resources. Submission of unsolicited resumes without a signed agreement and an applicable work order will not create an obligation on the part of Personalis to pay a fee of any kind. ABOUT Company Leadership Laboratory Careers Contact PRODUCTS Immuno-/Precision Oncology Oncology Clinical Diagnostics Pharma Research Solutions APPLICATIONS Biomarker Discovery Personalized Therapeutics Population Genomics TECHNOLOGY RESOURCES What’s New Conferences Library Publications Blog Contact INVESTORS © 2021 Personalis Inc. All rights reserved. info@personalis.com1 855-GENOME4 (436-6634)1 650-752-1300Privacy Policy We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Do not sell my personal information. Cookie Settings Accept

Skip to main navigation Copyright West LLC. Minimum 15 minutes delayed. Corporate Profile Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The company’s NeXT™ Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. Stock Information Change Volume 52 Week High 52 Week Low Nov 24, 2021 11:55 PM EST Data Provided by Refinitiv. Minimum 15 minutes delayed. View Details Corporate Presentations Nov 17, 2021 Personalis Investor Presentation - November 2021 View All Events Dec 1, 2021 33rd Annual Piper Sandler Virtual Healthcare Conference Nov 4, 2021 at 8:30 AM EDT Q3 2021 Personalis Earnings Conference Call Sep 20, 2021 at 9:00 AM EDT Personalis Update Call View All Recent Press Releases Nov 18, 2021 Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference Nov 12, 2021 Personalis Named to Inc.'s 2021 Best-Led Companies List View All Print Page RSS Feeds Email Alerts Contact IR Corporate Website © 2021 Personalis Inc. All rights reserved.